期刊
TRANSFUSION AND APHERESIS SCIENCE
卷 45, 期 3, 页码 251-256出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.transci.2011.10.003
关键词
Myasthenia gravis; Plasmapheresis; Immunotherapy; Myasthenic crisis; Extracorporeal elimination
类别
资金
- Ministry of Education, Youth and Sports, Czech Republic [MZO 0021620820]
- Ministry of Health, Czech Republic [MZO 00179906]
We describe our experience with plasma exchange (PE) and immunoadsorption in patients with myasthenia gravis. The group of 27 patients consists of 21 patients treated with PE and 6 patients who received immunoadsorption. PE therapy led to stabilization in 20 patients. In patients treated with immunoadsorption, therapy could be discontinued in 2 patients after 13 months of therapy, and the other 4 patients were stabilized without myasthenic crises after 6-9 years of therapy. Extracorporeal elimination therapy through PE or immunoadsorption is effective and sometimes life saving and is safe in the hands of an experienced team (6% complication rate). (C) 2011 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据